Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|24|2964-2978

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.24, 2013-08, pp. : 2964-2978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1387-1398

Bentham Science Publishers

Access to resources Recommend Favorite

Bcl-2 Family Proteins as Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 16, Iss. 28, 2010-09 ,pp. : 3132-3148

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 699-707

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Different Classes of Natural Products as Promising Scaffolds for the Development of Therapeutic Agents: New Drugs from “Old” Natural Products

By  

Current Medicinal Chemistry, Vol. 25, Iss. 10, 2018-04 ,pp. : 1092-1093

Bentham Science Publishers

Access to resources Recommend Favorite